ID
12317
Description
Randomized study with a run-in dose-selection phase to assess the added value of Lenalidomide in combination with standard remission-induction chemotherapy and post-remission treatment in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or high risk myelodysplasia (MDS) (IPSS-R risk score> 4.5) Description of Form: Lenalidomide Maintenance Treatment Form
Keywords
Versions (3)
- 11/9/15 11/9/15 -
- 12/28/15 12/28/15 -
- 2/11/16 2/11/16 -
Uploaded on
November 9, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Lenalidomide Maintenance Treatment Form HOVON 132 AML/SAKK 30/13 EudraCT 2013-002843-26
Lenalidomide Maintenance Treatment Form
- StudyEvent: ODM
Description
Treatment Administration
Description
Date start Lenalidomide
Data type
date
Measurement units
- dd/mm/yyyy
Alias
- UMLS CUI [1,1]
- C0808070
- UMLS CUI [1,2]
- C1144149
Description
Lenalidomide Total dose actually given
Data type
float
Measurement units
- mg
Alias
- UMLS CUI [1,1]
- C2986497
- UMLS CUI [1,2]
- C1144149
Description
Lenalidomide Dosage
Data type
integer
Alias
- UMLS CUI [1,1]
- C0178602
- UMLS CUI [1,2]
- C1144149
Description
Reason
Data type
integer
Alias
- UMLS CUI [1]
- C0420247
Description
Comments
Similar models
Lenalidomide Maintenance Treatment Form
- StudyEvent: ODM
C1144149 (UMLS CUI [1,2])
C1144149 (UMLS CUI [1,2])
C0013221 (UMLS CUI-2)